No Data
No Data
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
On July 26th, Chuangsheng Group-B (06628) spent approximately HKD 0.1864 million to repurchase 0.143 million shares.
Chuangsheng Group-B (06628) announced that it will spend about 0.1864 million Hong Kong dollars to buy back shares on July 26, 2024.
Chuangsheng Group-B (06628.HK) spent HK$0.099 million to repurchase 0.078 million shares on July 25
Gelonghui July 25 | Chuangsheng Group-B (06628.HK) announced that it spent HK$0.099 million to repurchase 0.078 million shares on July 25.
On July 24th, Chuangsheng Group-B (06628) spent about 0.089 million Hong Kong dollars to repurchase 0.075 million shares.
Chuangsheng Group-B (06628) announced that on July 24, 2024, it will spend about HKD 0.089 million to repurchase 0.075 million shares...
On July 23, Chuangsheng Group-B (06628.HK) spent HKD 0.0965 million to buy back 0.07 million shares.
On July 23rd, Creston Group-B (06628.HK) announced the repurchase of 0.07 million shares for HKD 0.0965 million.
On July 23rd, Chuangsheng Group-B (06628) spent 0.0965 million Hong Kong dollars to repurchase 0.07 million shares.
Chuangsheng Group-B (06628) announced that the company will spend 0.0965 million Hong Kong dollars on July 23, 2024...
No Data